The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Ganciclovir Treatment of Symptomatic Congenital Cytomegalovirus Infection: Results of a Phase II Study
Abstract
Congenital cytomegalovirus (CMV) infection occurs in approximately 1% of newborns in the United States. A phase II evaluation was done of ganciclovir for the treatment of symptomatic congenital CMV infection. Daily doses of 8 or 12 mg/kg were administered in divided doses at 12-h intervals for 6 weeks. Clinical and laboratory evaluations sought evidence of toxicity, quantitative virologic responses in urine, plasma drug concentrations, and clinical outcome. A total of 14 and 28 babies received 8 and 12 mg/kg/day, respectively. Five additional babies received ganciclovir on a compassionate plea basis. Significant laboratory abnormalities included thrombocytopenia (< or = 50,000/mm3) in 37 babies and absolute neutropenia (< or = 500 mm3) in 29 babies. Quantitative excretion of CMV in the urine decreased; however, after cessation of therapy, viruria returned to near pretreatment levels. Hearing improvement or stabilization occurred in 5 (16%) of 30 babies at 6 months or later, indicating efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Outcome of Congenital Cytomegalovirus Infection in Relation to Maternal Antibody Status
Fowler, K. B., Stagno, S., Pass, R. F., Britt, W. J., Boll, T. J., & Alford, C. A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203053261003 · Cited by 1,084
Self-citationStagno, S., Pass, R. F., Dworsky, M. E., Henderson, R. E., Moore, E. G., Walton, P. D., & Alford, C. A. (1982) · New England Journal of Medicine · doi:10.1056/nejm198204223061601 · Cited by 688
Self-citationThe Cytomegaloviruses: Ubiquitous Agents with Protean Clinical Manifestations: (Second of Two Parts)
Weller, T. H. (1971) · New England Journal of Medicine · doi:10.1056/nejm197107292850507 · Cited by 651
Roizman, B., Whitley, R. J., & Lopez, C. (1993) · Medical Entomology and Zoology · Cited by 294
Self-citationIncreased Rate of Cytomegalovirus Infection among Parents of Children Attending Day-Care Centers
Pass, R. F., Hutto, C., Ricks, R., & Cloud, G. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605293142204 · Cited by 226
Self-citationCongenital Cytomegalovirus Infection: A Fifteen Year Perspective
Hanshaw, J. B. (1971) · Journal of Infectious Diseases · doi:10.1093/infdis/123.5.555 · Cited by 221
Nigro, G., Scholz, H., & Bartmann, U. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70327-2 · Cited by 133
Trang, J. M., Kidd, L. B., Gruber, W. C., Storch, G. A., Demmler, G. J., Jacobs, R., Dankner, W. M., Starr, S. E., Pass, R. F., Stagno, S., et al. (1993) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1993.4 · Cited by 98
Self-citation
Cited by
Kimberlin, D. W., Lin, C.-Y., Sánchez, P. J., Demmler, G. J., Dankner, W., Shelton, M., Jacobs, R. F., Vaudry, W., Pass, R. F., Kiell, J. M., et al. (2003) · The Journal of Pediatrics · doi:10.1016/s0022-3476(03)00192-6 · Cited by 987
Self-citationRawlinson, W. D., Boppana, S. B., Fowler, K. B., Kimberlin, D. W., Lazzarotto, T., Alain, S., Daly, K., Doutré, S., Gibson, L., Giles, M. L., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30143-3 · Cited by 841
Diagnosis and Management of Human Cytomegalovirus Infection in the Mother, Fetus, and Newborn Infant
Revello, M. G., & Gerna, G. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.680-715.2002 · Cited by 618
Antiviral Drug Resistance of Human Cytomegalovirus
Lurain, N. S., & Chou, S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00009-10 · Cited by 596
The pathogenesis of human cytomegalovirus
Griffiths, P., Baraniak, I., & Reeves, M. (2015) · The Journal of Pathology · doi:10.1002/path.4437 · Cited by 592
Metadata
- Authors
- Whitley, R. J., Cloud, G., Gruber, W., Storch, G. A., Demmler, G. J., Jacobs, R. F., Dankner, W., Spector, S. A., Starr, S., Pass, R. F., Stagno, S., Britt, W. J., Alford, C., Soong, S., Zhou, X., Sherrill, L., FitzGerald, J. M., Sommadossi, J., & the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-05
- Volume
- 175
- Issue
- 5
- Pages
- 1080-1086
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2142682198
- Cited by
- 315
- References
- 8
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.